Psychological status and patient-assessed health instruments in ankylosing spondylitis

Journal of Clinical Rheumatology

Volumn 16, Issue 7, 2010, Pages 313-316

  Ortancil, Ozgur ^a   Konuk, Numan ^b   May, Hatice ^a   Sanli, Aslan ^a   Ozturk, Devrim ^a   Ankarali, Handan ^a  

^a Zonguldak Karaelmas Universitesi Tip Fakultesi   (Turkey)

^b ISTANBUL UNIVERSITY   (Turkey)

Author keywords

Ankylosing spondylitis; BASDAI; BASFI; BASMI; psychological status; SCL 90 R

Indexed keywords

ADULT; ANKYLOSING SPONDYLITIS; ANXIETY; ARTICLE; BATH ANKYLOSING SPONDYLITIS DISEASE ACTIVITY INDEX; BATH ANKYLOSING SPONDYLITIS FUNCTIONAL INDEX; BATH ANKYLOSING SPONDYLITIS METROLOGY INDEX; CHECKLIST; CLINICAL ARTICLE; CONTROLLED STUDY; DEPRESSION; DISABILITY; FEMALE; HOSTILITY; HUMAN; MALE; OBSESSIVE COMPULSIVE DISORDER; PARANOIA; PHOBIA; PRIORITY JOURNAL; PSYCHOSIS; SELF CONCEPT; SOMATIZATION; STATISTICAL ANALYSIS; SYMPTOM CHECKLIST 90;

ADULT; CASE-CONTROL STUDIES; COHORT STUDIES; DIAGNOSTIC SELF EVALUATION; FEMALE; HEALTH STATUS; HUMANS; MALE; MENTAL DISORDERS; PSYCHOLOGICAL TESTS; SEVERITY OF ILLNESS INDEX; SPONDYLITIS, ANKYLOSING;

EID: 78049272181     PISSN: 10761608     EISSN: None     Source Type: Journal    
DOI: 10.1097/RHU.0b013e3181f3bfba     Document Type: Article

References (28)

1. Sheehan NJ, Slavin BM, Donovan MP, et al. Lack of correlation between clinical disease activity and erythrocyte sedimentation rate, acute phase proteins or protease inhibitors in ankylosing spondylitis. Br J Rheumatol 1986;25(2):171-174.
2. Garrett S, Jenkinson T, Kennedy LG, et al. A new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Disease Activity Index. J Rheumatol 1994;21(12): 2286-2291.
3. Calin A, Garrett S, Whitelock H, et al. A new approach to defining functional ability in ankylosing spondylitis: the development of the Bath Ankylosing Spondylitis Functional Index. J Rheumatol 1994;21(12): 2281-2285.
4. McFarlane AC, Brooks PM. Determinants of disability in rheumatoid arthritis. Br J Rheumatol 1988;27(1):7-14.
5. Hidding A, de Witte L, van der Linden S. Determinants of self-reported health status in ankylosing spondylitis. J Rheumatol 1994;21(2): 275-278.
6. Zochling J, Braun J, van der Heijde D. Assessments in ankylosing spondylitis. Best Pract Res Clin Rheumatol 2006;20(3):521-537.
7. Derogatis LR. SCL-90-R: Administration, Scoring and Procedures Manual II for the Revised Version. Towson, MD: Clinical Psychometric Research; 1992.
8. Wallis BJ, Lord SM, Barnsley L, et al. Pain and psychologic symptoms of Australian patients with whiplash. Spine 1996;21(7):804-810.
9. Jenkinson TR, Mallorie PA, Whitelock HC, et al. Defining spinal mobility in ankylosing spondylitis (AS). The Bath AS Metrology Index. J Rheumatol 1994;21(9):1694-1698.
10. Akkoc Y, Karatepe AG, Akar S, et al. A Turkish version of the Bath Ankylosing Spondylitis Disease Activity Index: reliability and validity. Rheumatol Int 2005;25(4):280-284. (Pubitemid 40767833)
11. YanNk B, Gursel YK, Kutlay S, et al. Adaptation of the Bath Ankylosing Spondylitis Functional Index to the Turkish population, its reliability and validity: functional assessment in AS. Clin Rheumatol 2005;24(1):41-47.
12. Duckro PN, Margolis RB, Tait RC. Psychological assessment in chronic pain. J Clin Psychol 1985;41(4):499-504.
13. Dag I. Symptom Check List (SCL-90-R); a reliability and validity study [in Turkish]. Turk J Psychiatry 1991;2:5-12.
14. Ward MM. Quality of life in patients with ankylosing spondylitis. Rheum Dis Clin North Am 1998;24(4):815-827, x.
15. Peebles J, McWilliams L, MacLennan R. A comparison of symptom checklist 90-revised profiles from patients with chronic pain from whiplash and patients with other musculoskeletal injuries. Spine (Phila Pa 1976) 2001;26(7):766-770.
16. Taylor AG, Lorentzen LJ, Blank MB. Psychologic distress of chronic pain sufferers and their spouses. J Pain Symptom Manage 1990;5(1):6-10.
17. Hyphantis T, Bai M, Siafaka V, et al. Psychological distress and personality traits in early rheumatoid arthritis: a preliminary survey. Rheumatol Int 2006;26(9):828-836.
18. Basler HD. Group treatment for pain and discomfort. Patient Educ Couns 1993;20:167-175.
19. Barlow JH, Macey SJ, Struthers GR. Health locus of control, self-help and treatment adherence in relation to ankylosing spondylitis patients. Patient Educ Couns 1993;20(2-3):153-166.
20. Laurent MR, Panayi GS. Acute-phase proteins and serum immunoglobulins in ankylosing spondylitis. Ann Rheum Dis 1983;42(5):524-528.
21. Sanders KM, Hertzman A, Escobar MR, et al. Correlation of immunoglobulin and C reactive protein levels in ankylosing spondylitis and rheumatoid arthritis. Ann Rheum Dis 1987;46(4):273-276.
22. Collado A, Sanmarti R, Brancos MA, et al. Immunoglobulin A and C reactive protein levels in ankylosing spondylitis. Ann Rheum Dis 1987;46(9):719-720.
23. Kendall MJ, Lawrence DS, Shuttleworth GR, et al. Haematology and biochemistry ofankylosing spondylitis. Br Med J 1973;2(5860):235-237.
24. Dixon JS, Bird HA, Wright V. A comparison of serum biochemistry in ankylosing spondylitis, seronegative and seropositive rheumatoid arthritis. Ann Rheum Dis 1981;40(4):404-408.
25. Struthers GR, Lewin IV, Stanworth DR. IgA-alpha 1 antitrypsin complexes in ankylosing spondylitis. Ann Rheum Dis 1989;48(1):30-34.
26. Martindale J, Smith J, Sutton CJ, et al. Disease and psychological status in ankylosing spondylitis. Rheumatology (Oxford) 2006;45(10): 1288-1293.
27. Sierakowska M, Karpicska A, Sierakowski S, et al. Quality of life of patients with ankylosing spondylitis. Ann Acad Med Stetin 2006;52(Suppl 2):29-37.
28. Berthelot JM, Tortellier L, Lavy-Bregeon D, et al. High intraindividual week-to-week variability in BASDAI and BASFI values: are several evaluations needed before starting or stopping TNFalpha antagonist therapy for spondyloarthropathies? Joint Bone Spine 2008;75(2):167-171.